» Articles » PMID: 25492401

Hypoglycemia and Risk of Cardiovascular Disease and All-cause Mortality in Insulin-treated People with Type 1 and Type 2 Diabetes: a Cohort Study

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2014 Dec 11
PMID 25492401
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Hypoglycemia has been associated with an increased risk of cardiovascular (CV) events and all-cause mortality. This study assessed whether, in a nationally representative population, there is an association between hypoglycemia, the risk of CV events, and all-cause mortality among insulin-treated people with type 1 diabetes or type 2 diabetes.

Research Design And Methods: This retrospective cohort study used data from the Clinical Practice Research Datalink database and included all insulin-treated patients (≥30 years of age) with a diagnosis of diabetes.

Results: In patients who experienced hypoglycemia, hazard ratios (HRs) for CV events in people with type 1 diabetes were 1.51 (95% CI 0.83, 2.75; P = ns) and 1.61 (1.17, 2.22), respectively, for those with and without a history of CV disease (CVD) before the index date. In people with type 2 diabetes, the HRs for patients with and without a history of CVD were 1.60 (1.21, 2.12) and 1.49 (1.23, 1.82), respectively. For all-cause mortality, HRs in people with type 1 diabetes were 1.98 (1.25, 3.17), and 2.03 (1.66, 2.47), respectively, for those with and without a history of CVD. Among people with type 2 diabetes, HRs were 1.74 (1.39, 2.18) and 2.48 (2.21, 2.79), respectively, for those with and without a history of CVD. The median time (interquartile range) from first hypoglycemia event to first CV event was 1.5 years (0.5, 3.5 years) and 1.5 years (0.5, 3.0 years), respectively, for people with type 1 and type 2 diabetes.

Conclusions: Hypoglycemia is associated with an increased risk of CV events and all-cause mortality in insulin-treated patients with diabetes. The relationship between hypoglycemia and CV outcomes and mortality exists over a long period.

Citing Articles

Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk.

McCoy R, Swarna K, Neumiller J, Polley E, Deng Y, Mickelson M Clin Diabetes. 2025; 43(1):59-70.

PMID: 39829688 PMC: 11739335. DOI: 10.2337/cd24-0007.


A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus.

AlHabeeb W, Elasfar A, Kinsara A, Aljizeeri A, Jelaidan I, Alghalayini K J Saudi Heart Assoc. 2025; 36(4):385-407.

PMID: 39822337 PMC: 11737320. DOI: 10.37616/2212-5043.1407.


Glycemic Management of Patients with Hospital Hyperglycemia: A Retrospective Cohort Study on Adults Admitted in the Non-ICU Wards.

Zheng R, Zeng X, Shen R, Wang Y, Liu J, Zhang M Diabetes Metab Syndr Obes. 2025; 18():61-73.

PMID: 39802615 PMC: 11724696. DOI: 10.2147/DMSO.S501132.


Emotional Distress and Cardiovascular Health in Young Adults with Type 1 Diabetes.

Armentrout B, Ahmed B, Waraphok S, Huynh J, Griggs S J Cardiovasc Dev Dis. 2024; 11(12).

PMID: 39728281 PMC: 11676757. DOI: 10.3390/jcdd11120391.


The clinical importance of measuring glycaemic variability: Utilising new metrics to optimise glycaemic control.

Ajjan R Diabetes Obes Metab. 2024; 26 Suppl 7:3-16.

PMID: 39632776 PMC: 11646482. DOI: 10.1111/dom.16098.